Evidence map›Paper›PMID 16987961›Full record

ArticleMolecular biology of the cell2006

Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism.

François Renault-Mihara, Frédéric Beuvon, Xavier Iturrioz, Brigitte Canton, Sophie De Bouard, Nadine Léonard, Shahul Mouhamad, Ariane Sharif, Joe W Ramos, Marie-Pierre Junier and 1 more

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The PEA-15 protein regulates autophagy via activation of JNK.The Journal of biological chemistry · 2010
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

François Renault-MiharaInstitut National de la Santé et de la Recherche Médicale U752, Collège de France, 75005 Paris, France.
Frédéric Beuvon
Xavier Iturrioz
Brigitte Canton
Sophie De Bouard
Nadine Léonard
Shahul Mouhamad
Ariane Sharif
Joe W Ramos
Marie-Pierre Junier
Hervé Chneiweiss
Inserm · FRCentre Hospitalier Sainte-Anne · FRUniversity of Hawaiʻi at Mānoa · US

Funding

Regulation of Cell Signaling and AdhesionR01CA093849 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI RAMOS, JOE WILLIAM · 2002 to 2006
$1.2M
Regulation of Cell Signaling and AdhesionR56CA093849 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI RAMOS, JOE WILLIAM · 2007 to 2007
$230k
NCI NIH HHS CA-93849NCI NIH HHS R01 CA093849NCI NIH HHS R56 CA093849
6 · The paper itself

Abstract

Phosphoprotein enriched in astrocytes-15 kDa (PEA-15), a phosphoprotein enriched in astrocytes, inhibits both apoptosis and proliferation in normal and cancerous cells. Here, analysis of PEA-15 expression in glioblastoma organotypic cultures revealed low levels of PEA-15 in tumor cells migrating away from the explants, regardless of the expression levels in the originating explants. Because glioblastomas are highly invasive primary brain tumors that can originate from astrocytes, we explored the involvement of PEA-15 in the control of astrocyte migration. PEA-15-/- astrocytes presented an enhanced motility in vitro compared with their wild-type counterparts. Accordingly, NIH-3T3 cells transfected by green fluorescent protein-PEA-15 displayed a reduced migration. Reexpression of PEA-15 restored PEA-15-/- astrocyte motility to wild-type levels. Pharmacological manipulations excluded a participation of extracellular signal-regulated kinase/mitogen-activated protein kinase, phosphatidylinositol 3-kinase/Akt, and calcium/calmodulin-dependent protein kinase II in this effect of PEA-15. In contrast, treatment by bisindolylmaleimide, Gö6976, and rottlerin, and chronic application of phorbol 12-myristate 13-acetate and/or bryostatin-1 indicated that PKC delta mediated PEA-15 inhibition of astrocyte migration. PEA-15-/- astrocytes constitutively expressed a 40-kDa form of PKC delta that was down-regulated upon PEA-15 reexpression. Together, these data reveal a new function for PEA-15 in the inhibitory control of astrocyte motility through a PKC delta-dependent pathway involving the constitutive expression of a catalytic fragment of PKC delta.

Indexed as

Cell MovementActive Transport, Cell NucleusAnimalsApoptosis Regulatory ProteinsAstrocytesCalcium-Calmodulin-Dependent Protein KinasesCalcium-Calmodulin-Dependent Protein Kinase Type 2Cell NucleusCell ProliferationExtracellular Signal-Regulated MAP KinasesGlioblastomaHumansIntracellular Signaling Peptides and ProteinsMiceMolecular WeightNIH 3T3 CellsApoptosis Regulatory ProteinsCalcium-Calmodulin-Dependent Protein KinasesCalcium-Calmodulin-Dependent Protein Kinase Type 2Extracellular Signal-Regulated MAP KinasesIntracellular Signaling Peptides and ProteinsPEA15 protein, humanPhosphatidylinositol 3-KinasesPhosphoproteinsProtein Kinase C-deltaProto-Oncogene Proteins c-akt

Identifiers

PMID16987961
PMCPMC1679679
OpenAlexW2131865452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.